Lisata Therapeutics, Inc. LSTA 深 滬
已收盤 07-02 16:00:00 美东时间
3.33
-0.030
-0.89%
華盛通- 最 高3.36
- 今 開3.36
- 成交量 1.30万股
- 最 低 3.30
- 昨 收 3.36
- 總市值 3032.43万
- 52周最高 5.07
- 市盈率 靜 --
- 換手率 0.14%
- 52周最低 1.81
- 委 比 -99.97%
- 總股本 910.64万
- 歷史最高 1483.50
- 量 比 0.44
- 振 幅 1.79%
- 歷史最低 1.81
- 每 手 1
- 風險率 0.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kuva Acquisition Commences Tender Offer To Purchase All Issued And Outstanding Shares Of Common Stock Of Lisata Therapeutics For $4.00/Shr In Cash At Closing, Plus One Non-Tradeable Contingent Value Right
Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent value right, which represents the contractual right to receive two contingent cash payments of up to an aggregate of $3.00 per share, subject to achievement of specified milestones The transaction va...
06-10 20:04
Lisata Therapeutics, Kuva Labs extend merger offer start date to June 10
Lisata Therapeutics, Kuva Labs extend merger offer start date to June 10 Lisata Therapeutics’ merger deal with Kuva Labs was amended, shifting the tender offer launch to June 10 from June 1. The outside date moved to July 17 from July 1, with an optional extension to Aug. 17 tied to a USD 1.5 millio
06-09 19:31
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announced to acquire the homebuilder.
06-01 18:01
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during F...
05-30 05:05
HC Wainwright & Co. Downgrades Lisata Therapeutics to Neutral
HC Wainwright & Co. analyst Joseph Pantginis downgrades Lisata Therapeutics (NASDAQ:LSTA) from Buy to Neutral.
05-15 23:50
Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
05-15 05:22
Lisata Therapeutics Delays Tender Offer Launch in Merger
The latest update is out from Lisata Therapeutics ( ($LSTA) ). On April 2, 2026...
04-03 18:35
Lisata-Kuva Labs merger deal extends tender offer launch deadline to 26 business days
Lisata-Kuva Labs merger deal extends tender offer launch deadline to 26 business days Kuva Labs agreed to extend deadline to commence tender offer for Lisata to 26 business days from March 6, 2026, from 20 business days. Change was documented in waiver dated April 2, 2026, tied to merger agreement w
04-03 18:03
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Lisata Therapeutics announced it has agreed to be acquired by Kuva Labs for $5.00 per share in cash plus an additional $1.00 per share contingent on a future milestone. The board recommends stockholders tender shares, with the deal expected to close in Q2 2026. Upon completion, Lisata will become part of Kuva and delist from Nasdaq.
03-06 23:15
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
02-12 09:02
